RBM39 Enhances Cholangiocarcinoma Growth Through EZH2-mediated WNT7B/β-catenin Pathway
Nianli Liu(Xuzhou Medical College), Tong Wu(Tulane University)
Cited by 9
Related Papers
miR-185 Inhibits Hepatocellular Carcinoma Growth by Targeting the DNMT1/PTEN/Akt Pathway
|American Journal Of Pathology|2014|100
miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT
|PLoS ONE|2015|27
Improving radio-chemotherapy efficacy of prostate cancer by co-deliverying docetaxel and dbait with biodegradable nanoparticles
|Artificial Cells Nanomedicine and Biotechnology|2019|17